June 20, 2017 - By Migdalia James
DRDGOLD Limited is a gold mining company. The company has market cap of $134.64 million. The Firm is engaged in gold production by tailings retreatment. It has a 37.05 P/E ratio. The Firm is focused on the recovery of lower-risk, higher-margin ounces primarily from its metallurgical plant located approximately 50 kilometers east of Johannesburg in Brakpan.
Banbury Partners Llc increased Cdk Global Inc (CDK) stake by 36.46% reported in 2016Q4 SEC filing. Banbury Partners Llc acquired 122,983 shares as Cdk Global Inc (CDK)’s stock declined 6.12%. The Banbury Partners Llc holds 460,261 shares with $27.47M value, up from 337,278 last quarter. Cdk Global Inc now has $9.07 billion valuation. The stock declined 0.72% or $0.45 reaching $61.86 on the news. About 183,083 shares traded. CDK Global Inc (NASDAQ:CDK) has risen 18.92% since June 20, 2016 and is uptrending. It has outperformed by 2.22% the S&P500.
Ruffer Llp holds 0.41% of its portfolio in DRDGOLD Ltd. (ADR) for 1.32 million shares. Van Eck Associates Corp owns 5.71 million shares or 0.15% of their US portfolio. Moreover, Navellier & Associates Inc has 0.05% invested in the company for 53,887 shares. The New York-based National Asset Management Inc. has invested 0.03% in the stock. Oxford Asset Management, a United Kingdom-based fund reported 74,235 shares.
About 67,488 shares traded. DRDGOLD Ltd. (ADR) (DRD) has declined 30.98% since June 20, 2016 and is downtrending. It has underperformed by 47.68% the S&P500.
Among 4 analysts covering CDK Global (NASDAQ:CDK), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. CDK Global had 7 analyst reports since August 14, 2015 according to SRatingsIntel. The firm has “Neutral” rating by JP Morgan given on Wednesday, April 6. The stock of CDK Global Inc (NASDAQ:CDK) has “Equal-Weight” rating given on Friday, February 3 by Morgan Stanley. The rating was maintained by JP Morgan on Friday, August 14 with “Underweight”. The company was upgraded on Thursday, February 4 by Barrington Research. The rating was maintained by JP Morgan with “Underweight” on Tuesday, December 15. The stock has “Underweight” rating by Morgan Stanley on Tuesday, January 19.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.